Human bocavirus and KI/WU polyomaviruses in pediatric intensive care patients

Alma C van de Pol1, Tom F W Wolfs, Nicolaas J G Jansen

  • 1Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands. a.c.vandepol-3@umcutrecht.nl

Insights

Human bocavirus and polyomaviruses (KI and WU) were evaluated in pediatric intensive care patients. Prevalence was similar in children with and without lower respiratory tract infection (LRTI), suggesting these viruses are common in this population.

Area of Science:

  • Virology
  • Pediatric Infectious Diseases
  • Critical Care Medicine

Background:

  • Human bocavirus and polyomaviruses (KI and WU) are emerging viral pathogens.
  • Their role in pediatric lower respiratory tract infections (LRTI) requires further investigation.
  • Understanding viral prevalence in intensive care settings is crucial for diagnosis and management.

Purpose of the Study:

  • To determine the prevalence of human bocavirus and KI/WU polyomaviruses.
  • To compare viral detection rates in pediatric intensive care patients with and without LRTI.

Main Methods:

  • Retrospective analysis of respiratory samples from pediatric intensive care unit (PICU) patients.
  • Molecular detection methods (e.g., PCR) were used to identify target viruses.
  • Patients were categorized into groups based on the presence or absence of LRTI.

Main Results:

  • Human bocavirus was detected in 5.1% of patients with LRTI and 4.8% without LRTI.
  • KI polyomavirus was not detected in patients with LRTI but found in 4.8% of those without LRTI.
  • WU polyomavirus prevalence was 2.6% in patients with LRTI and 2.4% in those without LRTI.

Conclusions:

  • Human bocavirus and WU polyomavirus are frequently detected in pediatric intensive care patients, irrespective of LRTI status.
  • KI polyomavirus detection was limited to patients without LRTI in this cohort.
  • These findings highlight the common circulation of these viruses in critically ill children.

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...